MPO and chronic kidney disease: After pretreatment with farrerol, the contents of MDA and MPO, which are key to the ROS-induced imbalance of the CKD redox system, were greatly reduced, and the contents of the antioxidant enzymes GSH and SOD were increased (Figures 3A–D).